Last update 09 Jul 2025
INNOLIFE CO., LTD.

INNOLIFE CO., LTD.

Private Company | Subsidiary Company|2014|Sichuan Sheng, China|
www.innolife.com.cn

Overview

Tags

Cardiovascular Diseases
Nervous System Diseases
Digestive System Disorders
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Chemical drugs4
Small molecule drug1
Top 5 TargetCount
Cu x HIF-1α1

Related

5
Drugs associated with INNOLIFE CO., LTD.
Trientine Hydrochloride
Target
Cu x HIF-1α
Mechanism
Cu modulators [+1]
Active Org.
Frontage Laboratories, Inc.Frontage Laboratories, Inc. [+9]
Originator Org.
Bausch Health Americas, Inc.
Active Indication
Hepatolenticular Degeneration [+4]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date08 Nov 1985
INL-2
Target-
Mechanism-
Active Org.
INNOLIFE CO., LTD.INNOLIFE CO., LTD.
Originator Org.
INNOLIFE CO., LTD.INNOLIFE CO., LTD.
Active Indication
Brain Infarction
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
INL-5
Target-
Mechanism-
Active Org.
INNOLIFE CO., LTD.INNOLIFE CO., LTD.
Originator Org.
INNOLIFE CO., LTD.INNOLIFE CO., LTD.
Active Indication
Liver Cirrhosis
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with INNOLIFE CO., LTD.
NCT03875183
/ Unknown statusPhase 2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction
100 Clinical Results associated with INNOLIFE CO., LTD.
Login to view more data
0 Patents (Medical) associated with INNOLIFE CO., LTD.
Login to view more data
100 Deals associated with INNOLIFE CO., LTD.
Login to view more data
100 Translational Medicine associated with INNOLIFE CO., LTD.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
4
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Trientine Hydrochloride
 ( Cu x HIF-1α )		Heart Failure
More
Phase 2
INL-2
Brain Infarction
More
Preclinical
INL-5
Liver Cirrhosis
More
Preclinical
INL-3
Hypertension
More
Preclinical
INL-4
Arteriosclerosis
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free